04th week of 2021 patent applcation highlights part 10 |
Patent application number | Title | Published |
20210023185 | FACTOR IX POLYPEPTIDES AND METHODS OF USE THEREOF | 2021-01-28 |
20210023186 | POLYMER FACTOR IX MOIETY CONJUGATES | 2021-01-28 |
20210023187 | Targeted Thrombolysis for Treatment of Microvascular Thrombosis | 2021-01-28 |
20210023188 | COCCIDIOIDES ANTIGENS AND METHODS OF THEIR USE | 2021-01-28 |
20210023189 | NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS OF THE BLOOD, SUCH AS ACUTE MYELOID LEUKEMIA (AML) | 2021-01-28 |
20210023190 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NHL AND OTHER CANCERS | 2021-01-28 |
20210023191 | VACCINE COMPOSITIONS COMPRISING TRYPTOPHAN 2,3-DIOXYGENASE OR FRAGMENTS THEREOF | 2021-01-28 |
20210023192 | IMMUNOGENIC COMPOSITION COMPRISING STAPHYLOCOCCAL ANTIGENS | 2021-01-28 |
20210023193 | STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF | 2021-01-28 |
20210023194 | POLYPEPTIDES OF FUSOBACTERIUM AND METHODS OF USE | 2021-01-28 |
20210023195 | COMPOSITIONS AND METHODS FOR VACCINATION AGAINST RESPIRATORY SYNCITIAL VIRUS INFECTION | 2021-01-28 |
20210023196 | MULTI-CBV VACCINE FOR PREVENTING OR TREATING TYPE I DIABETES | 2021-01-28 |
20210023197 | INFLUENZA VIRUS VECTORS AND USES THEREFOR | 2021-01-28 |
20210023198 | MUTANT OF HEMAGGLUTININ PROTEIN OF H3N2 SUBTYPE INFLUENZA VIRUS AND USE THEREOF | 2021-01-28 |
20210023199 | VACCINATION WITH mRNA-CODED ANTIGENS | 2021-01-28 |
20210023200 | RSV F Protein Mutants | 2021-01-28 |
20210023201 | COMPOSITIONS AND METHODS FOR GLIOBLASTOMA TREATMENT | 2021-01-28 |
20210023202 | Human Cytomegalovirus Immunogenic Composition | 2021-01-28 |
20210023203 | BIVALENT VACCINE COMPOSITION FOR PREVENTING AND/OR TREATING PORCINE CIRCOVIRUS INFECTIONS AND PREPARATION METHOD AND USE THEREOF | 2021-01-28 |
20210023204 | METHODS FOR PREVENTING DENGUE AND HEPATITIS A | 2021-01-28 |
20210023205 | VIRUS LIKE PARTICLE PRODUCTION IN PLANTS | 2021-01-28 |
20210023206 | COMPOSITION FOR THE TREATMENT OF TYPE I ALLERGIC HYPERSENSITIVITIES BY IMMUNE DESENSITIZATION THROUGH SLIT IMMUNOTHERAPY WITH UNADULTERATED ALLERGEN, VITAMIN A, VITAMIN D AND AN IMMUNO-EFFECTIVE AMOUNT OF ADJUVANT OF ESSENTIAL OILS | 2021-01-28 |
20210023207 | NOVEL INTEGRIN ACTIVATOR VACCINE COMPOSITIONS | 2021-01-28 |
20210023208 | EXPRESSION VECTOR DELIVERY SYSTEM AND USE THEREOF FOR INDUCING AN IMMUNE RESPONSE | 2021-01-28 |
20210023209 | ANTIGENIC PEPTIDES DERIVING FROM PCSK2 AND USES THEREOF FOR THE DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES | 2021-01-28 |
20210023210 | IVIG TREATMENTS FOR BELL'S PALSY | 2021-01-28 |
20210023211 | COMBINATION OF ANTI-FGFR4-ANTIBODY AND BILE ACID SEQUESTRANT | 2021-01-28 |
20210023212 | IMMUNE MOTIFS IN PRODUCTS FROM DOMESTIC ANIMALS | 2021-01-28 |
20210023213 | CANCER TREATMENTS | 2021-01-28 |
20210023214 | ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF | 2021-01-28 |
20210023215 | LIQUID PHARMACEUTICAL COMPOSITION | 2021-01-28 |
20210023216 | STABLE AQUEOUS ANTI-TAU ANTIBODY FORMULATIONS | 2021-01-28 |
20210023217 | PROTEINS MODIFIED WITH (AMINO) MONOSACCHARIDE-BIOTIN ADDUCT | 2021-01-28 |
20210023218 | METHODS FOR PROMOTING MYELINATION AND FOR TREATING DEMYELINATING DISEASES | 2021-01-28 |
20210023219 | CELL ASSEMBLY-MEDIATED DELIVERY OF CHECKPOINT INHIBITORS FOR CANCER IMMUNOTHERAPY | 2021-01-28 |
20210023220 | HIGH LOAD DISPERSIONS | 2021-01-28 |
20210023221 | CONDUCTIVE POLYMER GRAPHENE OXIDE COMPOSITE MATERIALS | 2021-01-28 |
20210023222 | OXYMETAZOLINE COMPOSITIONS | 2021-01-28 |
20210023223 | HYDROCARBON / LIPID - CAROTENOID COMPLEXES | 2021-01-28 |
20210023224 | BRANCHED MULTI-FUNCTIONAL MACROMONOMERS AND RELATED POLYMERS AND USES THEREOF | 2021-01-28 |
20210023225 | COMPOSITIONS AND METHODS FOR EFFICIENT DELIVERY OF MOLECULES TO CELLS | 2021-01-28 |
20210023226 | SURFACTANT-FREE, WATER-FREE FOAMABLE COMPOSITION AND BREAKABLE FOAMS AND THEIR USES | 2021-01-28 |
20210023227 | Methods And Compositions For Templated Assembly Of Nucleic Acid Specific Heterocompounds | 2021-01-28 |
20210023228 | IMMUNOSUPPRESSIVE MATERIALS AND RELATED METHODS | 2021-01-28 |
20210023229 | METHODS FOR IMPROVED PROTECTION AND DELIVERY OF AMINOTHIOLS AND ANALOGS THEREOF | 2021-01-28 |
20210023230 | CONJUGATES OF AN IL-2 MOIETY AND A POLYMER | 2021-01-28 |
20210023231 | DEGRADABLE POLYETHYLENE GLYCOL CONJUGATE | 2021-01-28 |
20210023232 | COMBINATION OF POLYETHYLENE GLYCOL AND RAPAMYCIN AND USE THEREOF | 2021-01-28 |
20210023233 | ANTIBODY-PEPTIDE COMPLEXES AND USES THEREOF | 2021-01-28 |
20210023234 | ECTONUCLEOTIDE PYROPHOSPHATE-PHOSPHODIESTERASE (ENPP) CONJUGATES AND USES THEREOF | 2021-01-28 |
20210023235 | BLOCK COPOLYMERS | 2021-01-28 |
20210023236 | MULTI-TARGETED, TUNABLE, SUSTAINED DELIVERY OF PAYLOADS TO CHARGED AVASCULAR TISSUES | 2021-01-28 |
20210023237 | THERAPEUTIC COMBINATIONS COMPRISING ANTI-CD123 IMMUNOCONJUGATES | 2021-01-28 |
20210023238 | TRIPTOLIDE ANTIBODY CONJUGATES | 2021-01-28 |
20210023239 | THERAPEUTIC NANOPARTICLES CONTAINING ARGONAUTE FOR MICRORNA DELIVERY AND COMPOSITIONS AND METHODS USING SAME | 2021-01-28 |
20210023240 | Thermoresponsive Injectable Microparticles-Gel Composites with Low Dose of Recombinant BMP-9 and VEGF for Bone Repair | 2021-01-28 |
20210023241 | GENE THERAPEUTICS FOR TREATING BONE DISORDERS | 2021-01-28 |
20210023242 | TREATMENT OF DEAFNESS BY GENE THERAPY | 2021-01-28 |
20210023243 | ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR AND METHODS OF USE THEREOF | 2021-01-28 |
20210023244 | SUBLINGUAL AND BUCCAL ADMINISTRATIONS OF FLUORESCENT AGENTS FOR OPTICAL IMAGING | 2021-01-28 |
20210023245 | Antimicrobial Backlit Device | 2021-01-28 |
20210023246 | SYSTEMS AND METHODS FOR COMBINED HIGH INTENSITY NARROW SPECTRUM AND NON-HIGH INTENSITY NARROW SPECTRUM LIGHTING FOR SURFACE DISINFECTION IN VARIABLY OCCUPIED ENVIRONMENTS | 2021-01-28 |
20210023247 | STERILIZATION DEVICE | 2021-01-28 |
20210023248 | DISINFECTING APPARATUS | 2021-01-28 |
20210023249 | SELF-SANITIZING WAVEGUIDING SURFACES | 2021-01-28 |
20210023250 | DEVICES, SYSTEMS, AND METHODS FOR STERILIZATION, DISINFECTION, SANITIZATION AND DECONTAMINATION | 2021-01-28 |
20210023251 | Sterilization Lamp Module Integrated in Vehicle and Vehicle Comprising a Sterilization Lamp Module | 2021-01-28 |
20210023252 | INTERIOR MATERIAL HAVING DEODORANT, ANTIMICROBIAL SURFACE LAYER AND PRODUCTION METHOD THEREOF | 2021-01-28 |
20210023253 | AIR FRESHENER FOR VEHICLES | 2021-01-28 |
20210023254 | PERFUME RETAINING STRUCTURE, METHOD OF MANUFACTURING THE PERFUME RETAINING STRUCTURE, AND SCENT PROVIDING DEVICE | 2021-01-28 |
20210023255 | REACTION CORE SYSTEM FOR PHOTOCATALYTIC PURIFIERS | 2021-01-28 |
20210023256 | HYDROGEL WOUND DRESSING AND METHOD OF PREPARING THE SAME | 2021-01-28 |
20210023257 | CEREBROSPINAL FLUID LEAKAGE OCCLUSION | 2021-01-28 |
20210023258 | HYDRATABLE AND FLOWABLE IMPLANTABLE COMPOSITIONS AND METHODS OF MAKING AND USING THEM | 2021-01-28 |
20210023259 | POLY (IONIC LIQUID) COMPOSITIONS AND THEIR USE AS TISSUE ADHESIVES | 2021-01-28 |
20210023260 | COMPOSITION FOR HARD TISSUE REPAIR AND KIT FOR HARD TISSUE REPAIR | 2021-01-28 |
20210023261 | POLYMERIC TREATMENT COMPOSITIONS | 2021-01-28 |
20210023262 | COMPOSITION AND DRESSING WITH NITRIC OXIDE | 2021-01-28 |
20210023263 | IMPLANTABLE CALCIUM PHOSPHATE COMPOSITIONS AND METHODS | 2021-01-28 |
20210023264 | USE OF IMMUNE MODULATORS TO IMPROVE NERVE REGENERATION | 2021-01-28 |
20210023265 | DERMAL FILLER COMPOSITIONS INCLUDING ANTIOXIDANTS | 2021-01-28 |
20210023266 | TECHNIQUES FOR PROMOTING NEURONAL RECOVERY | 2021-01-28 |
20210023267 | POLYMER-PERMEATED GRAFTS AND METHODS OF MAKING AND USING THE SAME | 2021-01-28 |
20210023268 | BONE REPAIR PRODUCT AND METHODS OF USE THEREOF | 2021-01-28 |
20210023269 | BONE REGENERATION MATERIAL HAVING A COTTON-WOOL LIKE STRUCTURE FORMED OF A PLURALITY OF ELECTROSPUN FIBERS | 2021-01-28 |
20210023270 | BONE GEL COMPOSITION AND METHOD OF MANUFACTURE | 2021-01-28 |
20210023271 | MALLEABLE DEMINERALIZED BONE COMPOSITION AND METHOD OF MANUFACTURE | 2021-01-28 |
20210023272 | INTESTINAL TISSUE ENHANCED WITH THERAPEUTIC SALTS | 2021-01-28 |
20210023273 | METHOD AND DEVICE FOR PREPARING AN IMPLANT OBTAINED FROM A CULTURE OF STEM CELLS | 2021-01-28 |
20210023274 | POLAND SYNDROME AND METHODS OF TREATMENT | 2021-01-28 |
20210023275 | Scaffold for living donor transplantation | 2021-01-28 |
20210023276 | Coatings | 2021-01-28 |
20210023277 | ANTIMICROBIAL INSERTS FOR MEDICAL DEVICES | 2021-01-28 |
20210023278 | POROUS BIOABSORBABLE IMPLANT | 2021-01-28 |
20210023279 | SYSTEMS INCLUDING EXTERNAL CATHETER FOR AUTOMATICALLY COLLECTING URINE FROM A FEMALE PATIENT AND METHODS OF USE | 2021-01-28 |
20210023280 | Medical Lavage Device | 2021-01-28 |
20210023281 | METHOD TO DYNAMICALLY MEASURE APPOSITION AND PATIENT LIMB MOVEMENT IN A NEGATIVE PRESSURE CLOSED INCISION DRESSING | 2021-01-28 |
20210023282 | BLOOD PUMP | 2021-01-28 |
20210023283 | APPARATUS FOR EXTRACORPOREAL BLOOD TREATMENT | 2021-01-28 |
20210023284 | METHOD FOR OPERATING A SUPPLY DEVICE WHICH SUPPLIES A LIQUID TO A CHANNEL, AND SUPPLY DEVICE, HOLLOW CATHETER, AND CATHETER PUMP | 2021-01-28 |